©2026 Bryn Mawr Communications, LLC.
All Rights Reserved

Terms and Conditions • Privacy Policy

Contributor:

Charles C. Wykoff, MD PhD

Phase 3 Faricimab Data and the Dawn of a New Molecule
Phase 3 Faricimab Data and the Dawn of a New Molecule

Ramin Tadayoni, MD, PhD and Charles Wykoff, MD, PhD

1-Year Primary Outcome Data From RECOVERY
1-Year Primary Outcome Data From RECOVERY

Charles Wykoff, MD, PhD

Suprachoroidal Steroids for DME
Suprachoroidal Steroids for DME

Charles Wykoff, MD, PhD

Revisiting VISTA: Nonperfusion and Aflibercept
Revisiting VISTA: Nonperfusion and Aflibercept

Charles Wykoff, MD, PhD